The American Society for Radiation Oncology (ASTRO) has issued a new guideline on adjuvant radiotherapy in locally advanced non-small cell lung cancer (NSCLC).
The guideline's executive summary is published in the May-June issue of Practical Radiation Oncology. The complete guideline cites 35 years of data to help guide current treatment and future research and is available online as an open-access article in the journal.
The guideline covers the following:
- Ideal external-beam dose fractionation for curative-intent treatment of locally advanced NSCLC with radiotherapy alone without chemotherapy
- Ideal external-beam dose fractionation for curative-intent treatment of locally advanced NSCLC with chemotherapy
- Ideal timing of external-beam radiation therapy in relation to systemic chemotherapy for curative-intent treatment of locally advanced NSCLC
- Indications for adjuvant postoperative radiation therapy for curative-intent treatment of locally advanced NSCLC
- When neoadjuvant radiotherapy or chemoradiation prior to surgery is indicated for curative-intent treatment of locally advanced NSCLC
